Tirzepatide Tablets UK | Mounjaro from £135.00 | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro UK Price - From £124.99 Online

Get Mounjaro at the cheapest UK price from £124.99 plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman starting a weight loss consultation on the Cured Pharmacy website

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Tirzepatide Tablets - Complete Dose Range Available

Published on: June 03, 2026

Many UK patients search for tirzepatide tablets UK online as an alternative to injections. Currently, tirzepatide is licensed in the UK exclusively as Mounjaro KwikPen injections, available from £124.99 at Cured Pharmacy. Whilst oral formulations are under clinical investigation, the injectable form remains the only MHRA-approved option for weight management in the UK.

Understanding Tirzepatide: Current UK Availability

Tirzepatide is a dual GIP/GLP-1 receptor agonist licensed by the MHRA under the brand name Mounjaro for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. The medication works by activating two incretin hormone pathways simultaneously, producing superior weight loss outcomes compared to single-pathway treatments.

In the landmark SURPASS-2 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks—the highest efficacy demonstrated by any approved weight management medication to date [1]. These results have positioned tirzepatide as a first-line consideration for patients who meet clinical criteria.

Currently, tirzepatide is manufactured and supplied exclusively as a once-weekly subcutaneous injection in pre-filled KwikPen devices. The complete UK dose range includes 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg strengths, allowing for gradual titration to minimise gastrointestinal side effects whilst optimising therapeutic response.

Why Tirzepatide Is Not Available as Tablets in the UK

Tirzepatide is a large peptide molecule consisting of 39 amino acids, making it unsuitable for oral administration in its current formulation [2]. Like insulin and other peptide hormones, tirzepatide would be rapidly degraded by digestive enzymes in the stomach and intestines before reaching systemic circulation, rendering oral tablets ineffective.

Pharmaceutical manufacturers are investigating novel delivery technologies—including absorption enhancers, protective coatings, and alternative formulations—to develop oral GLP-1 receptor agonists. Semaglutide (Rybelsus) represents the only oral GLP-1 medication currently licensed in the UK, though it requires specific administration protocols and achieves lower bioavailability than injectable forms [2].

For patients seeking non-injectable weight management options, Cured Pharmacy offers alternative treatments including Orlistat, Mysimba, and other licensed medications. These oral formulations work through different mechanisms—lipase inhibition or appetite regulation—and may be appropriate for individuals unable or unwilling to use injectable therapies.

Injection Technique and Patient Support

Modern tirzepatide pens are designed for ease of use, featuring single-dose pre-filled devices that require no manual dose selection or refrigeration after first use. The subcutaneous injection is administered into the abdomen, thigh, or upper arm using a fine 32-gauge needle, with most patients reporting minimal discomfort.

Our clinical team at Cured Pharmacy provides comprehensive injection training resources, including video demonstrations and written guidance reviewed by superintendent pharmacist Tarun Kumar (GPhC 2233073). Patients typically achieve confidence with self-administration within the first two doses, and telephone support remains available throughout treatment.

Complete Mounjaro Dose Range: Titration Schedule

Tirzepatide therapy follows a structured dose escalation protocol designed to improve gastrointestinal tolerability whilst achieving optimal weight loss outcomes [3]. All patients commence treatment with the 2.5mg starter dose, administered once weekly for four weeks. This initial phase allows the body to adapt to the medication's effects on gastric emptying and appetite regulation.

After the first month, the dose increases to 5mg weekly for an additional four weeks. Subsequent dose escalations occur at four-week intervals—progressing through 7.5mg, 10mg, 12.5mg, and ultimately 15mg—based on individual response and tolerability. UK prescribers assess weight loss progress, side effect profile, and metabolic parameters at each titration point to determine appropriate dose advancement [3].

Clinical trial data demonstrates that higher maintenance doses produce greater weight reduction, with the 15mg dose achieving superior outcomes in head-to-head comparisons [1]. However, not all patients require maximum dosing; your prescriber will identify the lowest effective dose that achieves your treatment goals whilst maintaining acceptable tolerability.

Dose Adjustments and Treatment Duration

If intolerable gastrointestinal side effects occur during titration, your prescriber may recommend maintaining your current dose for an additional four weeks before attempting further escalation. Alternatively, dose reduction to the previous strength remains an option, with re-escalation attempted once symptoms resolve.

Long-term treatment duration varies based on individual response and clinical goals. NICE guidance supports continued use of GLP-1 receptor agonists for chronic weight management when patients demonstrate sustained benefit, defined as maintenance of clinically significant weight loss and improvement in weight-related comorbidities [4].

Treatment Active Ingredient Administration Starting Price
Mounjaro Tirzepatide Once weekly injection From £124.99
Wegovy Semaglutide Once weekly injection From £69.00
Saxenda Liraglutide Daily injection From £68.00
Orlistat Orlistat 120mg Oral capsule (three times daily) From £32.00
Mysimba Naltrexone/Bupropion Oral tablet (twice daily) From £125.95

Mounjaro vs Alternative Weight Loss Treatments

UK patients have access to several MHRA-licensed weight management medications, each working through distinct physiological mechanisms. Tirzepatide (Mounjaro) represents the most recently approved option and demonstrates the highest average weight loss in clinical trials, attributed to its dual incretin receptor activity [1].

Semaglutide-based treatments (Wegovy) function as selective GLP-1 receptor agonists, producing average weight reductions of 15-17% over 68 weeks in the STEP trial programme [5]. Whilst highly effective, semaglutide's single-pathway mechanism results in modestly lower efficacy compared to tirzepatide's dual action. Wegovy follows a similar once-weekly injection schedule and shares a comparable side effect profile.

Liraglutide (Saxenda) requires daily subcutaneous injection and achieves average weight loss of 8-9% over 56 weeks [6]. The daily administration schedule may suit patients who prefer more frequent dosing with lower per-injection medication volumes. Orlistat-based treatments work peripherally by inhibiting pancreatic lipase, reducing dietary fat absorption by approximately 30% and producing average weight loss of 3-5% when combined with dietary modification.

Mysimba combines naltrexone and bupropion to modulate central appetite pathways, offering an oral alternative for patients who cannot use injectable therapies. Clinical trials demonstrate average weight reductions of 5-9% over 56 weeks, with response rates improving when combined with behavioural interventions [7].

Clinical Efficacy: What the Evidence Shows

The SURPASS clinical trial programme evaluated tirzepatide across multiple study populations, consistently demonstrating superior weight loss compared to placebo and active comparators [1]. In SURPASS-3, participants receiving 15mg tirzepatide achieved mean weight reduction of 22.5% at 72 weeks, with 63% of patients losing at least 20% of baseline body weight—a threshold associated with substantial cardiometabolic benefits.

Beyond weight reduction, tirzepatide therapy produces clinically meaningful improvements in obesity-related comorbidities. Trial participants demonstrated significant reductions in HbA1c (average decrease of 2.0-2.5% in patients with type 2 diabetes), systolic blood pressure (average reduction of 5-8 mmHg), and markers of cardiovascular risk including triglycerides and inflammatory markers [1][3].

Head-to-head comparison against semaglutide 1mg in SURPASS-2 revealed tirzepatide's superior efficacy, with all three tirzepatide dose levels (5mg, 10mg, 15mg) producing significantly greater weight loss than the GLP-1 comparator [1]. These findings have informed UK prescribing patterns, with tirzepatide increasingly considered for patients requiring maximum weight reduction or those with inadequate response to single-pathway treatments.

Long-Term Weight Maintenance

Extension studies demonstrate sustained weight loss maintenance with continued tirzepatide therapy, contrasting with the weight regain typically observed after medication discontinuation [3]. Patients maintaining treatment beyond the initial trial periods showed stable weight trajectories, supporting the chronic disease management model for obesity treatment advocated by NICE and other UK guideline bodies.

Starting Treatment at Cured Pharmacy

Accessing tirzepatide through Cured Pharmacy begins with a comprehensive online clinical assessment completed by UK-registered prescribers. The consultation evaluates your medical history, current medications, weight management goals, and contraindications to ensure tirzepatide represents a safe and appropriate treatment option. Assessment completion typically requires under three minutes, with prescribing decisions communicated within 24 hours on working days.

All Mounjaro supplies dispensed by Cured Pharmacy originate from UK-licensed wholesalers and meet MHRA quality standards. Transparent pricing from £124.99 is displayed before consultation, with no hidden fees or subscription requirements. Discreet packaging ensures confidentiality, and our GPhC-registered pharmacy team remains available for ongoing clinical support throughout your treatment journey.

Prescription medications require clinical approval by a UK prescriber before dispensing. Not all patients will be suitable candidates for tirzepatide therapy; contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, and severe gastrointestinal disease. Your prescriber will review your individual circumstances to determine the most appropriate weight management strategy for your needs.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Buckley, S. T., Bækdal, T. A., Vegge, A., et al. (2018). Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine, 10(467), eaar7047. https://doi.org/10.1126/scitranslmed.aar7047 [accessed 13 August 2026]
  3. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
  4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
  5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  6. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
  7. Greenway, F. L., Fujioka, K., Plodkowski, R. A., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595-605. https://doi.org/10.1016/S0140-6736(10)60888-4 [accessed 13 August 2026]
  8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and not all patients will be suitable candidates for tirzepatide therapy.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Are tirzepatide tablets available in the UK?
No, tirzepatide is currently only licensed in the UK as Mounjaro injections. Oral formulations are under investigation but not yet approved by the MHRA for clinical use.
How much does Mounjaro cost at Cured Pharmacy?
Mounjaro starts from £124.99 at Cured Pharmacy, with transparent pricing displayed before your free online consultation. Final cost depends on your prescribed dose and treatment duration.
Can I switch from Mounjaro injections to tablets?
Tirzepatide tablets are not currently available in any UK pharmacy. Patients seeking oral weight loss medications may consider alternatives like Orlistat or Mysimba, subject to prescriber approval.
Do I need a prescription for tirzepatide in the UK?
Yes, tirzepatide (Mounjaro) is a prescription-only medication requiring clinical assessment by a UK-registered prescriber before dispensing. Cured Pharmacy provides free online consultations with prescribing decisions typically within 24 hours.
What is the starting dose for Mounjaro?
All patients commence tirzepatide therapy with the 2.5mg dose, administered once weekly for four weeks. Doses are then titrated upward at four-week intervals based on individual response and tolerability.
How effective is Mounjaro compared to Wegovy?
Clinical trials show tirzepatide (Mounjaro) produces average weight loss of 22.5% at 72 weeks compared to 15-17% with semaglutide (Wegovy), attributed to tirzepatide's dual GIP/GLP-1 receptor activity.
Are there oral alternatives to tirzepatide injections?
Yes, Cured Pharmacy offers oral weight loss treatments including Orlistat (lipase inhibitor) and Mysimba (appetite modulator). These work through different mechanisms and may suit patients unable to use injectable therapies.
How long does Mounjaro treatment last?
Treatment duration varies based on individual response and clinical goals. NICE supports long-term use of GLP-1 therapies for chronic weight management when patients demonstrate sustained benefit and tolerability.
Can I buy tirzepatide tablets UK online from Cured Pharmacy?
Yes, Cured Pharmacy offers Mounjaro (tirzepatide) online with a UK-registered prescriber review included. After completing a short medical questionnaire, a prescriber will assess your suitability and issue a prescription if appropriate.
Are tirzepatide tablets UK online cheaper than getting Mounjaro from my GP?
Mounjaro is not currently available on the NHS for weight loss, so you would need a private prescription from your GP. Cured Pharmacy offers competitive pricing from £124.99 with £20 off your first order using code Weightlossnew, often making it more affordable and convenient than private GP appointments.
How quickly can I receive tirzepatide tablets UK online after ordering?
Cured Pharmacy offers next-day delivery on Mounjaro orders placed before the cut-off time. Once your prescription is approved by a UK prescriber, your medication is dispatched discreetly and typically arrives within 1-2 working days.
Does the price of Mounjaro increase as I move up doses?
Yes, Mounjaro pricing increases with dose strength. Starting at £124.99 for 2.5mg, prices rise to £159 for 5mg, £200 for 7.5mg, £225 for 10mg, £250 for 12.5mg, and £267 for 15mg at Cured Pharmacy.
Can I use discount code Weightlossnew on all tirzepatide tablets UK online orders?
The Weightlossnew code gives you £20 off your first Mounjaro order at Cured Pharmacy. This one-time discount applies to any starting dose, bringing the 2.5mg starter dose down to just £104.99.
Can I order tirzepatide tablets UK online from Cured Pharmacy?
Mounjaro (tirzepatide) is available as an injection pen, not tablets, and you can order it online from Cured Pharmacy after completing a quick consultation. Our UK-registered prescribers will review your health details and issue a prescription if suitable, with fast delivery direct to your door.
How does the tirzepatide tablets UK online price at Cured Pharmacy compare to other pharmacies?
Cured Pharmacy offers Mounjaro at the cheapest UK price starting from £124.99 for the 2.5mg dose, with an additional £20 off your first order using code Weightlossnew. This pricing is highly competitive compared to other UK online pharmacies and private clinics.
Is Mounjaro available on the NHS or only through private tirzepatide tablets UK online services?
Mounjaro is currently very limited on the NHS and typically restricted to type 2 diabetes patients meeting strict criteria. Most people access tirzepatide through private online pharmacies like Cured Pharmacy, where availability is guaranteed and treatment can start quickly with no waiting lists.
Can I use a discount code when ordering tirzepatide tablets UK online from Cured Pharmacy?
Yes, new customers can save £20 off their first Mounjaro order at Cured Pharmacy using code Weightlossnew at checkout. This discount applies to all starting doses and is automatically applied when you enter the code during your online purchase.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.